Testing effectiveness (Phase 2)Ended earlyNCT02862600
What this trial is testing
Open-Label Study of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure
Who this might be right for
Cardiomyopathy, HypertrophicCardiomyopathy, Hypertrophic, Familial
Heart Metabolics Limited 35